Bicycle Therapeutics Plc (BCYC)
7.495
+0.40
(+5.71%)
USD |
NASDAQ |
Dec 10, 16:00
7.495
0.00 (0.00%)
After-Hours: 16:59
Bicycle Therapeutics Profit Margin (Quarterly): -503.7% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Adaptimmune Therapeutics Plc | -221.8% |
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | -- |
| Autolus Therapeutics Plc | -373.3% |
| Mereo BioPharma Group Plc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -34.37% |
| Return on Assets | -28.31% |
| Return on Invested Capital | -33.95% |
| Gross Profit Margin (Quarterly) | 85.04% |
| Operating Margin (Quarterly) | -624.9% |
| Return on Net Operating Assets | -1.59K% |